BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30034623)

  • 1. Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs.
    Węglarz-Tomczak E; Talma M; Giurg M; Westerhoff HV; Janowski R; Mucha A
    Oncotarget; 2018 Jun; 9(50):29365-29378. PubMed ID: 30034623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of methionine aminopeptidase 2 as a molecular target of the organoselenium drug ebselen and its derivatives/analogues: Synthesis, inhibitory activity and molecular modeling study.
    Węglarz-Tomczak E; Burda-Grabowska M; Giurg M; Mucha A
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5254-5259. PubMed ID: 27692546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel non-competitive inhibitors of mammalian neutral M1 aminopeptidase (APN).
    Pascual I; Valiente PA; García G; Valdés-Tresanco ME; Arrebola Y; Díaz L; Bounaadja L; Uribe RM; Pacheco MC; Florent I; Charli JL
    Biochimie; 2017 Nov; 142():216-225. PubMed ID: 28964831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Actinomycin D and its mechanisms of action].
    Koba M; Konopa J
    Postepy Hig Med Dosw (Online); 2005; 59():290-8. PubMed ID: 15995596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening.
    Ruggeri C; Drinkwater N; Sivaraman KK; Bamert RS; McGowan S; Paiardini A
    PLoS One; 2015; 10(9):e0138957. PubMed ID: 26406322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modifications of actinomycin D structure as example of actinomycins structure-activity relationship].
    Koba M
    Postepy Hig Med Dosw (Online); 2005; 59():276-82. PubMed ID: 15995594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structural insight into the P1S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases.
    Węglarz-Tomczak E; Berlicki Ł; Pawełczak M; Nocek B; Joachimiak A; Mucha A
    Eur J Med Chem; 2016 Jul; 117():187-96. PubMed ID: 27100031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.
    Marino JP; Fisher PW; Hofmann GA; Kirkpatrick RB; Janson CA; Johnson RK; Ma C; Mattern M; Meek TD; Ryan MD; Schulz C; Smith WW; Tew DG; Tomazek TA; Veber DF; Xiong WC; Yamamoto Y; Yamashita K; Yang G; Thompson SK
    J Med Chem; 2007 Aug; 50(16):3777-85. PubMed ID: 17636946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese.
    Wang J; Sheppard GS; Lou P; Kawai M; Park C; Egan DA; Schneider A; Bouska J; Lesniewski R; Henkin J
    Biochemistry; 2003 May; 42(17):5035-42. PubMed ID: 12718546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
    Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
    Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition.
    Warder SE; Tucker LA; McLoughlin SM; Strelitzer TJ; Meuth JL; Zhang Q; Sheppard GS; Richardson PL; Lesniewski R; Davidsen SK; Bell RL; Rogers JC; Wang J
    J Proteome Res; 2008 Nov; 7(11):4807-20. PubMed ID: 18828628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.
    Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A
    Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties.
    Kawai M; BaMaung NY; Fidanze SD; Erickson SA; Tedrow JS; Sanders WJ; Vasudevan A; Park C; Hutchins C; Comess KM; Kalvin D; Wang J; Zhang Q; Lou P; Tucker-Garcia L; Bouska J; Bell RL; Lesniewski R; Henkin J; Sheppard GS
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3574-7. PubMed ID: 16632353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action.
    Luciani N; Marie-Claire C; Ruffet E; Beaumont A; Roques BP; Fournié-Zaluski MC
    Biochemistry; 1998 Jan; 37(2):686-92. PubMed ID: 9425092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model.
    Chun E; Han CK; Yoon JH; Sim TB; Kim YK; Lee KY
    Int J Cancer; 2005 Mar; 114(1):124-30. PubMed ID: 15523682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine aminopeptidase 2 and cancer.
    Selvakumar P; Lakshmikuttyamma A; Dimmock JR; Sharma RK
    Biochim Biophys Acta; 2006 Apr; 1765(2):148-54. PubMed ID: 16386852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
    Wang J; Lou P; Henkin J
    J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.
    Sheppard GS; Wang J; Kawai M; Fidanze SD; BaMaung NY; Erickson SA; Barnes DM; Tedrow JS; Kolaczkowski L; Vasudevan A; Park DC; Wang GT; Sanders WJ; Mantei RA; Palazzo F; Tucker-Garcia L; Lou P; Zhang Q; Park CH; Kim KH; Petros A; Olejniczak E; Nettesheim D; Hajduk P; Henkin J; Lesniewski R; Davidsen SK; Bell RL
    J Med Chem; 2006 Jun; 49(13):3832-49. PubMed ID: 16789740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.
    Schmitt C; Voegelin M; Marin A; Schmitt M; Schegg F; Hénon P; Guenot D; Tarnus C
    Bioorg Med Chem; 2013 Apr; 21(7):2135-44. PubMed ID: 23428964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial multicomponent access to natural-products-inspired peptidomimetics: discovery of selective inhibitors of microbial metallo-aminopeptidases.
    Méndez Y; Pérez-Labrada K; González-Bacerio J; Valdés G; de los Chávez MÁ; Osuna J; Charli JL; Pascual I; Rivera DG
    ChemMedChem; 2014 Oct; 9(10):2351-9. PubMed ID: 24989844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.